Study to Evaluate the Efficacy and Safety of PF-06651600 and PF-06700841 to Treat Moderate to Severe Alopecia Areata in Adults
A Phase 2a Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety Profile of PF-06651600 and PF-06700841 in Subjects With Moderate to Severe Alopecia Areata With a Single-Blind Extension Period and a Cross-Over Open Label Extension Period
Category & Conditions: Immune System Diseases and Conditions
Medicine: PF-06651600
PF-06700841
ClinicalTrials.gov Identifier (NCT): NCT02974868
Protocol ID: B7931005
PrintDownloadOpen Plain Language Summary Result: Click here